John P. Lynch, M.D.

Associate Professor of Medicine

CONTACT INFORMATION

Washington University School of Medicine
660 S. Euclid Avenue, Campus Box 8052
St. Louis, MO 63110
(314) 454-8766 (phone)
(314) 454-5571 (fax)

EDUCATION/TRAINING

Under-Graduate Education:
B.A.: St. Louis University, St. Louis, Missouri, 1983

Graduate Education:
Medical Degree: George Washington University, Washington, District of Columbia, 1989

Residency (Internal Medicine):
Residency: Internal Medicine, Barnes Hospital, St. Louis, Missouri, 1991

Fellowship (Pulmonary Disease and Critical Care Medicine):
Washington University School of Medicine, St. Louis, Missouri

POSITIONS

Washington University School of Medicine, St. Louis, MO
Associate Professor of Medicine

PUBLICATIONS

Books

Lynch JP, Trulock EP, Cooper JD. The perioperative care of lung transplant recipients. Eds. Bone RC, Dantzker DR, George RB, Matthay RA, Reynolds HY. Pulmonary and Critical Care Medicine. Chicago: Mosby-Year Book, Inc, 1998

Journal Articles

Paranjothi S, Yusen RD, Kraus MD, Lynch JP, Patterson GA, Trulock EP. Lymphoproliferative disease after lung transplantation: Comparison of presentation and outcome of early and late cases. J Heart Lung Transplant 2001; 20:1054-1063

Sanchez JL, Kruger RM, Paranjothi S, Trulock EP, Lynch JP, Hicks C, Shannon WD, Storch GA. Relationship of cytomegalovirus viral load in blood to pneumonitis in lung transplant recipients. Transplantation 2001; 72:733-735

Rizzo M, SivaSai KS, Smith MA, Trulock EP, Lynch JP, Patterson GA, Mohanakumar T. Increased expression of inflammatory cytokines and adhesion molecules by alveolar macrophages of human lung allograft recipients with acute rejection: Decline with resolution of rejection. J Heart Lung Transplant 2000; 19:858-865

Meyers BF, Lynch JP, Battafarano RJ, Guthrie TJ, Trulock EP, Cooper JD, Patterson GA. Lung transplantation is warranted for stable, ventilator-dependent recipients. Ann Thorac Surg 2000; 70:1675-1678

Lynch JP, Forman SA, Graff SI, Gunby MC. High-risk population health management – achieving improved patient outcomes and near-term financial results. The American J Managed Care 2000; 6(7):781-791, 31-41

Vizza CD, Yusen RD, Lynch JP, Fedele F, Patterson GA, Trulock EP. Outcome of patients with cystic fibrosis awaiting lung transplantation. 2000, In Press

Meyers BF, Lynch JP, Trulock EP, Guthrie T, Cooper JD, Patterson GA. Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: A ten-year institutional experience. J Thorac Cardiovasc Surg 2000; 120:99-107

SivaSai KSR, Smith MA, Poindexter NJ, Sundaresan SR, Trulock EP, Lynch JP, Cooper JD, Patterson GA, Mohanakumar T. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans dyndrome. Transplantation 1999; 67:1094-1094

Jaramillo A, Smith MA, Phelan D, Sundaresan S, Trulock EP, Lynch JP, Cooper JD, Patterson GA, Mohankumar T. Development of Eliza-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation 1999; 67:1155-1161

Kruger RM, Shannon WD, Arens MQ, Lynch JP, Storch GA, Trulock EP. The impact of Gancyclovir-resistant cytomegalovirus infection after lung transplantation. Transplantation 1999; Vol 68:1272-1279, No. 9

Meyers BF, Lynch JP, Trulock EP, Guthrie TJ, Cooper JD, Patterson GA. Lung transplantation: A decade of experience. Annals of Surgery 1999; 230:362-371

Calhoun R, SivaSai KSR, Sundaresan S, Trulock EP, Lynch JP, Patterson GA, Cooper JD, Mohanakumar T. Development of bronchiolitis obliterans syndrome despite blood chimerism in human lung transplant recipients. Transpl Int 1999; 12:439-446


Division of Pulmonary and Critical Care Medicine
Department of Medicine
Washington University School of Medicine